Chiral Technologies

Daicel Chiral Technologies, a subsidiary of Japan's Daicel Corporation, is the world's foremost provider of chiral separation technologies and services. The company pioneered the chiral chromatography industry nearly four decades ago and maintains market leadership through continuous innovation, a portfolio of over 1,200 chiral column products, and unmatched technical expertise. It serves pharmaceutical companies, academic researchers, and other life science sectors—including agrochemicals, veterinary medicine, and flavor/fragrance—by enabling the rapid and cost-effective isolation of single-enantiomer compounds critical for drug development and product innovation.

Proprietary chiral stationary phases (CSPs) for chromatography, including polysaccharide-based, protein-based, and amino acid-based selectors, along with immobilized phases for robust method development and enantiomer separation.

The main competitors are large chromatography vendors like Waters and Agilent, and specialized suppliers like Phenomenex and Regis Technologies. Daicel differentiates itself through its singular focus on chirality, the industry's broadest product portfolio, over 40 years of application knowledge, and a reputation as the technical leader and most trusted partner for solving challenging separations.